SEQUENT

Sequent Scientific Share Price

₹192.63 -3.29 (-1.68%)

17 Nov, 2024 21:12

SIP TrendupStart SIP in SEQUENT

Start SIP

Performance

  • Low
  • ₹186
  • High
  • ₹198
  • 52 Week Low
  • ₹92
  • 52 Week High
  • ₹241
  • Open Price₹191
  • Previous Close₹196
  • Volume640,462

Investment Returns

  • Over 1 Month 0.03%
  • Over 3 Month + 34.42%
  • Over 6 Month + 64.43%
  • Over 1 Year + 96.56%
SIP Lightning

Smart Investing Starts Here Start SIP with Sequent Scientific for Steady Growth!

Invest Now

Sequent Scientific Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 238
  • PEG Ratio
  • 2.1
  • Market Cap Cr
  • 4,809
  • P/B Ratio
  • 6.7
  • Average True Range
  • 11.25
  • EPS
  • 0.78
  • Dividend Yield
  • 0
  • MACD Signal
  • 4.13
  • RSI
  • 48.21
  • MFI
  • 64.72

Sequent Scientific Financials

Sequent Scientific Technicals

EMA & SMA

Current Price
₹192.63
-3.29 (-1.68%)
pointer
  • stock-down_img
  • Bullish Moving Average 7
  • stock-up_img
  • Bearish Moving Average 9
  • 20 Day
  • ₹197.57
  • 50 Day
  • ₹188.14
  • 100 Day
  • ₹172.49
  • 200 Day
  • ₹152.82

Resistance and Support

192.25 Pivot Speed
  • R3 210.26
  • R2 204.13
  • R1 198.38
  • S1 186.50
  • S2 180.37
  • S3 174.62

What's your outlook on Sequent Scientific?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Sequent Scientific Ltd. is a leading animal health company in India, specializing in the manufacturing of veterinary pharmaceuticals, including APIs and formulations. It serves global markets with a strong focus on quality, compliance, and innovation.

Sequent Scientific has an operating revenue of Rs. 1,449.42 Cr. on a trailing 12-month basis. An annual revenue de-growth of -3% needs improvement, Pre-tax margin of -4% needs improvement, ROE of -5% is poor and needs improvement. The company has a reasonable debt to equity of 22%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 32% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. It is currently FORMING a base in its weekly chart and is trading around 19% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 53 which is a POOR score indicating inconsistency in earnings, a RS Rating of 85 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 40 indicates it belongs to a strong industry group of Medical-Diversified and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Sequent Scientific Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-13 Quarterly Results
2024-08-14 Quarterly Results
2024-05-15 Audited Results & Final Dividend
2024-02-13 Quarterly Results
2023-11-06 Quarterly Results
Date Purpose Remarks
2021-09-10 FINAL Rs.0.50 per share(25%)Final Dividend

Sequent Scientific F&O

Sequent Scientific Shareholding Pattern

52.76%
7.41%
6.45%
24%
9.38%

About Sequent Scientific

  • NSE Symbol
  • SEQUENT
  • BSE Symbol
  • 512529
  • Managing Director & CEO
  • Mr. Rajaram Narayanan
  • ISIN
  • INE807F01027

Similar Stocks to Sequent Scientific

Sequent Scientific FAQs

Sequent Scientific share price is ₹192 As on 17 November, 2024 | 20:58

The Market Cap of Sequent Scientific is ₹4808.9 Cr As on 17 November, 2024 | 20:58

The P/E ratio of Sequent Scientific is 238 As on 17 November, 2024 | 20:58

The PB ratio of Sequent Scientific is 6.7 As on 17 November, 2024 | 20:58

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
 
footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23